Role of prions in neuroprotection and neurodegeneration

References

• DeArmond SJ, Prusiner SB. Perspectives on prion biology, prion disease pathogenesis and pharmacologic approaches to treatment. Clin Lab Med 2003; 23:1 - 41
   PubMed Web of Science ®Google Scholar
• Prusiner SB, Scott MR, DeArmond SJ, Cohen FE. Prion protein biology. Cell 1998; 93:337 - 348
   PubMed Web of Science ®Google Scholar
• Moore RA, Taubner LM, Priola SA. Prion protein misfolding and disease. Curr Opin Struct Biol 2009; 19:14 - 22
   PubMed Web of Science ®Google Scholar
• DeArmond SJ. Discovering the mechanisms of neurodegeneration in prion diseases. Neurochem Res 2004; 29:1979 - 1998
   PubMed Web of Science ®Google Scholar
• Linden R, Martins VR, Prado MA, Cammarota M, Izquierdo I, Brentani RR. Physiology of the prion protein. Physiol Rev 2008; 88:673 - 728
   PubMed Web of Science ®Google Scholar
• Will RG, Alpers MP, Dormont D, Schonberger LB. Prusiner SB. Infectious and Sporadic Prion Diseases. “Prion biology and diseases” 2004; 13:629 - 672
   Google Scholar
• Fournier JG, Escaig-Haye F, Grigoriev V. Ultrastructural localization of prion proteins: physiological and pathological implications. Microsc Res Tech 2000; 50:76 - 88
   PubMed Web of Science ®Google Scholar
• Salés N, Rodolfo K, Hässig R, Faucheux B, Di Giamberardino L, Moya KL. Cellular prion protein localization in rodent and primate brain. Eur J Neurosci 1998; 10:2464 - 2471
   PubMed Web of Science ®Google Scholar
• Sakudo A, Onodera T, Suganuma Y, Kobayashi T, Saeki K, Ikuta K. Recent advances in clarifying prion protein functions using knockout mice and derived cell lines. Mini Rev Med Chem 2006; 6:589 - 601
   PubMed Web of Science ®Google Scholar
• Steele AD, Lindquist S, Aguzzi A. The prion protein knockout mouse: A phenotype under challenge. Prion 2007; 1:83 - 93
   PubMed Web of Science ®Google Scholar
• Bueler H, Fischer M, Lang Y, Bluethmann H, Lipp HP, DeArmond SJ, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992; 356:577 - 582
   PubMed Web of Science ®Google Scholar
• Criado JR, Sanchez-Alavez M, Conti B, Giacchino JL, Wills DN, Henriksen SJ, et al. Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis 2005; 19:255 - 265
   PubMed Web of Science ®Google Scholar
• Collinge J, Whittington MA, Sidle KC, Smith CJ, Palmer MS, Clarke AR, Jefferys JG. Prion protein is necessary for normal synaptic function. Nature 1994; 370:295 - 297
   PubMed Web of Science ®Google Scholar
• Maglio LE, Perez MF, Martins VR, Brentani RR, Ramirez OA. Hippocampal synaptic plasticity in mice devoid of cellular prion protein. Brain Res Mol Brain Res 2004; 131:58 - 64
   PubMedGoogle Scholar
• Maglio LE, Martins VR, Izquierdo I, Ramirez OA. Role of cellular prion protein on LTP expression in aged mice. Brain Res 2006; 1097:11 - 18
   PubMed Web of Science ®Google Scholar
• Manson JC, Hope J, Clarke AR, Johnston A, Black C, MacLeod N. PrP gene dosage and long term potentiation. Neurodegeneration 1995; 4:113 - 114
   PubMedGoogle Scholar
• Curtis J, Errington M, Bliss T, Voss K, MacLeod N. Age-dependent loss of PTP and LTP in the hippocampus of PrP-null mice. Neurobiol Dis 2003; 13:55 - 62
   PubMed Web of Science ®Google Scholar
• Colling SB, Collinge J, Jefferys JG. Hippocampal slices from prion protein null mice: disrupted Ca(2+)-activated K+ currents. Neurosci Lett 1996; 209:49 - 52
   PubMed Web of Science ®Google Scholar
• Colling SB, Khana M, Collinge J, Jefferys JG. Mossy fibre reorganization in the hippocampus of prion protein null mice. Brain Res 1997; 755:28 - 35
   PubMed Web of Science ®Google Scholar
• Mallucci GR, Ratté S, Asante EA, Linehan J, Gowland I, Jefferys JG, Collinge J. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 2002; 21:202 - 210
   PubMed Web of Science ®Google Scholar
• Baumann F, Tolnay M, Brabeck C, Pahnke J, Kloz U, Niemann HH, et al. Lethal recessive myelin toxicity of prion protein lacking its central domain. EMBO J 2007; 26:538 - 547
   PubMed Web of Science ®Google Scholar
• Li A, Christensen HM, Stewart LR, Roth KA, Chiesa R, Harris DA. Neonatal lethality in transgenic mice expressing prion protein with a deletion of residues 105–125. EMBO J 2007; 26:548 - 558
   PubMed Web of Science ®Google Scholar
• Radovanovic I, Braun N, Giger OT, Mertz K, Miele G, Prinz M, et al. Truncated prion protein and Doppel are myelinotoxic in the absence of oligodendrocytic PrPC. J Neurosci 2005; 25:4879 - 4888
   PubMed Web of Science ®Google Scholar
• Moore RC, Lee IY, Silverman GL, Harrison PM, Strome R, Heinrich C, et al. Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppel. J Mol Biol 1999; 292:797 - 817
   PubMed Web of Science ®Google Scholar
• Vassallo N, Herms J. Cellular prion protein function in copper homeostasis and redox signalling at the synapse. J Neurochem 2003; 86:538 - 544
   PubMed Web of Science ®Google Scholar
• McLennan NF, Brennan PM, McNeill A, Davies I, Fotheringham A, Rennison KA, et al. Prion protein accumulation and neuroprotection in hypoxic brain damage. Am J Pathol 2004; 165:227 - 235
   PubMed Web of Science ®Google Scholar
• Shyu WC, Lin SZ, Chiang MF, Ding DC, Li KW, Chen SF, et al. Overexpression of PrPC by adenovirus-mediated gene targeting reduces ischemic injury in a stroke rat model. J Neurosci 2005; 25:8967 - 8977
   PubMed Web of Science ®Google Scholar
• Spudich A, Frigg R, Kilic E, Kilic U, Oesch B, Raeber A, et al. Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1/-2 and STAT-1. Neurobiol Dis 2005; 20:442 - 449
   PubMed Web of Science ®Google Scholar
• Weise J, Crome O, Sandau R, Schulz-Schaeffer W, Bahr M, Zerr I. Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity. Neurosci Lett 2004; 372:146 - 150
   PubMed Web of Science ®Google Scholar
• Walz R, Amaral OE, Rockenbach IC, Roesler R, Izquierdo I, Cavalheiro EA, et al. Increased sensitivity to seizures in mice lacking cellular prion protein. Epilepsia 1999; 40:1679 - 1682
   PubMed Web of Science ®Google Scholar
• Rangel A, Burgaya F, Gavin R, Soriano E, Aguzzi A, Del Rio JA. Enhanced susceptibility of Prnp-deficient mice to kainate-induced seizures, neuronal apoptosis and death: Role of AMPA/kainate receptors. J Neurosci Res 2007; 85:2741 - 2755
   PubMed Web of Science ®Google Scholar
• Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457:1128 - 1132
   PubMed Web of Science ®Google Scholar
• Arundine M, Tymianski M. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury. Cell Mol Life Sci 2004; 61:657 - 668
   PubMed Web of Science ®Google Scholar
• Mody I, MacDonald JF. NMDA receptor-dependent excitotoxicity: the role of intracellular Ca2+ release. Trends Pharmacol Sci 1995; 16:356 - 359
   PubMed Web of Science ®Google Scholar
• Olney JW, Collins RC, Sloviter RS. Excitotoxic mechanisms of epileptic brain damage. Adv Neurol 1986; 44:857 - 877
   PubMedGoogle Scholar
• Micu I, Jiang Q, Coderre E, Ridsdale A, Zhang L, Woulfe J, et al. NMDA receptors mediate Ca accumulation in central nervous system myelin during chemical ischemia. Nature 2006; 439:988 - 992
   PubMed Web of Science ®Google Scholar
• Khosravani H, Zhang Y, Tsutsui S, Hameed S, Altier C, Hamid J, et al. Prion protein attenuates excitotoxicity by inhibiting NMDA receptors. J Cell Biol 2008; 181:551 - 565
   PubMed Web of Science ®Google Scholar
• Cull-Candy SG, Leszkiewicz DN. Role of distinct NMDA receptor subtypes at central synapses. Sci STKE 2004; 255:16
   Google Scholar
• Riemer C, Burwinkel M, Schwarz A, Gültner S, Mok SW, Heise I, et al. Evaluation of drugs for treatment of prion infections of the central nervous system. J Gen Virol 2008; 89:594 - 597
   PubMed Web of Science ®Google Scholar